BNT162b2 boosted neutralizing antibody titers after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination

被引：0
|
作者：
Hammerschmidt, S. I. [1 ]
Barros-Martins, J. [1 ]
Cossmann, A. [2 ]
Ramos, G. Morillas [2 ]
Stankow, M. V. [2 ]
Odak, I. [1 ]
Dopfer-Jablonka, A. [2 ,3 ]
Hetzel, L. [2 ]
Koehler, M. [1 ]
Patzer, G. [1 ]
Binz, C. [1 ]
Ritter, C. [1 ]
Friedrichsen, M. [1 ]
Schultze-Florey, C. [1 ,4 ]
Ravens, I. [1 ]
Willenzon, S. [1 ]
Bubke, A. [1 ]
Ristenpart, J. [1 ]
Janssen, A. [1 ]
Ssebyatika, G. [5 ]
Kraehling, V. [6 ,7 ]
Bernhardt, G. [1 ]
Hoffmann, M. [8 ,9 ]
Poehlmann, S. [8 ,9 ]
Krey, T. [5 ,10 ]
Bosnjak, B. [1 ]
Foester, R. [1 ,3 ,11 ]
Behrens, G. M. N. [2 ,3 ,12 ]
机构：
[1] Hannover Med Sch, Inst Immunol, Hannover, Germany
[2] Hannover Med Sch, Dept Rheumatol & Immunol, Hannover, Germany
[3] German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig, Hannover, Germany
[4] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany
[5] Univ Lubeck, Inst Biochem, Lubeck, Germany
[6] Philipps Univ Marburg, Inst Virol, Marburg, Germany
[7] German Ctr Infect Res DZIF, Partner Site Giessen Marburg Langen, Marburg, Germany
[8] German Primate Ctr, Infect Biol Unit, Gottingen, Germany
[9] Georg August Univ Gottingen, Fac Biol & Psychol, Hannover, Germany
[10] German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig & Partner Site, Hamburg, Germany
[11] Hannover Med Sch, Cluster Excellence RESIST EXC 2155, Hannover, Germany
[12] Ctr Individualized Infect Med CiiM, Hannover, Germany
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2022年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P 005
引用
收藏
页码：154 / 155
页数：2
相关论文
共 50 条
  • [21] Erythema Multiforme after BNT162b2 Vaccination
    Katayama, Sho
    Ota, Mitsuhito
    INTERNAL MEDICINE, 2022, 61 (12) : 1929 - 1929
  • [22] Immune Responses After Vaccination With Primary 2-Dose ChAdOx1 Plus a Booster of BNT162b2 or Vaccination With Primary 2-Dose BNT162b2 Plus a Booster of BNT162b2 and the Occurrence of Omicron Breakthrough Infection
    Choi, Seong-Ho
    Park, Ji Young
    Kweon, Oh Joo
    Park, Joung Ha
    Kim, Min-Chul
    Lim, Yaeji
    Chung, Jin-Won
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2023, 38 (20)
  • [23] Correlation between Reactogenicity and Immunogenicity after the ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccination
    Lim, So Yun
    Kim, Ji Yeun
    Park, Soonju
    Kwon, Ji-Soo
    Park, Ji Young
    Cha, Hye Hee
    Suh, Mi Hyun
    Lee, Hyun Jung
    Lim, Joon Seo
    Bae, Seongman
    Jung, Jiwon
    Lee, Nakyung
    Kim, Kideok
    Shum, David
    Jee, Youngmee
    Kim, Sung-Han
    IMMUNE NETWORK, 2021, 21 (06)
  • [24] Humoral and cellular responses to vaccination with homologous CoronaVac or ChAdOx1 and heterologous third dose with BNT162b2
    Hayashi, Jackelinne Y.
    Simizo, Adriana
    Miyamoto, Jackson G.
    Costa, Lucas V. S.
    Souza, Olivia F.
    Chiarelli, Tassia
    Bacarov, Natalia B. S.
    Hidalgo, Rafaela
    Garcia, Leticia D.
    Soane, Michel M.
    Braconi, Carla T.
    Maricato, Juliana T.
    Janini, Luiz M.
    Salomao, Reinaldo
    Popi, Ana F.
    Glezer, Isaias
    Bonetti, Tatiana
    Tashima, Alexandre K.
    JOURNAL OF INFECTION, 2022, 84 (06) : 866 - 868
  • [25] Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2
    Vogel, Emanuel
    Kocher, Katharina
    Priller, Alina
    Cheng, Cho-Chin
    Steininger, Philipp
    Liao, Bo-Hung
    Korber, Nina
    Willmann, Annika
    Irrgang, Pascal
    Held, Juergen
    Moosmann, Carolin
    Schmidt, Viviane
    Beileke, Stephanie
    Wytopil, Monika
    Heringer, Sarah
    Bauer, Tanja
    Brockhoff, Ronja
    Jeske, Samuel
    Mijocevic, Hrvoje
    Christa, Catharina
    Salmanton-Garcia, Jon
    Tinnefeld, Kathrin
    Bogdan, Christian
    Yazici, Sarah
    Knolle, Percy
    Cornely, Oliver A.
    Ueberla, Klaus
    Protzer, Ulrike
    Schober, Kilian
    Tenbusch, Matthias
    EBIOMEDICINE, 2022, 85
  • [26] Evaluation of Antibody Response to Heterologous Prime-Boost Vaccination with ChAdOx1 nCoV-19 and BNT162b2: An Observational Study
    Firinu, Davide
    Perra, Andrea
    Campagna, Marcello
    Littera, Roberto
    Meloni, Federico
    Sedda, Francesca
    Conti, Maria
    Costanzo, Giulia
    Erbi, Monica
    Usai, Gianmario
    Locci, Carlotta
    Carta, Mauro Giovanni
    Cappai, Riccardo
    Orru, Germano
    Del Giacco, Stefano
    Coghe, Ferdinando
    Chessa, Luchino
    VACCINES, 2021, 9 (12)
  • [27] BNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes
    Abdul-Jawad, Sultan
    Beatson, Richard
    Lechmere, Thomas
    Graham, Rosalind
    Alaguthurai, Thanussuyah
    Graham, Carl
    Vidler, Jennifer
    Kulasekararaj, Austin
    Patten, Piers E. M.
    Doores, Katie J.
    Irshad, Sheeba
    HAEMATOLOGICA, 2022, 107 (05) : 1181 - 1184
  • [28] Safety and immunogenicity of heterologous ChAdOx1-nCoV19 and BNT162b2 vaccination: A meta-analysis of the heterologous COVID-19 vaccination outcomes
    Hu, Yuxuan
    Wang, Yanning
    Shao, Taihang
    Tang, Wenxi
    Hu, Kerong
    Zhou, Yujie
    Miao, Liyun
    Liu, Jing
    Wang, Bin
    Yu, Wenying
    VACCINE, 2023, 41 (18) : 3003 - 3010
  • [29] Immunogenicity and Durability of Antibody Responses to Homologous and Heterologous Vaccinations with BNT162b2 and ChAdOx1 Vaccines for COVID-19
    Kim, Dong-In
    Lee, Seo Jin
    Park, Soonju
    Kim, Paul
    Lee, Sun Min
    Lee, Nakyung
    Shum, David
    Kim, Dong Ho
    Kim, Eui Ho
    VACCINES, 2022, 10 (11)
  • [30] Acute interstitial nephritis after vaccination with BNT162b2
    Rieckmann, Sonja
    Seibert, Felix S.
    Hogeweg, Maximilian
    Bertram, Sebastian
    Doevelaar, Adrian A. N.
    Amann, Kerstin
    Babel, Nina
    Westhoff, Timm H.
    JOURNAL OF NEPHROLOGY, 2022, 35 (03) : 779 - 782
12345